Cytomegalovirus infection in non-immunosuppressed critically ill patients

Journal of Infection in Developing Countries

Volumn 5, Issue 8, 2011, Pages 571-579

  Jain, Manisha ^a   Duggal, Shalini ^b   Chugh, Tulsi Das ^b  

^a G B PANT HOSPITAL   (India)

^b B L Kapur Memorial Hospital   (India)

Author keywords

CMV; Critically ill; ICU patients; Reactivation

Indexed keywords

ACICLOVIR; BENZIMIDAVIR; CIDOFOVIR; FOSCARNET; GANCICLOVIR; VALACICLOVIR; VALGANCICLOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLERGIC REACTION; BONE MARROW SUPPRESSION; BURN; CONVULSION; CRITICALLY ILL PATIENT; CYTOMEGALOVIRUS INFECTION; ELECTROLYTE DISTURBANCE; EPIDEMIOLOGY; GRAFT RECIPIENT; HALLUCINATION; HEMATOLOGIC DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENCE; IMMUNOSUPPRESSIVE TREATMENT; INJURY; INTENSIVE CARE UNIT; LIVER CIRRHOSIS; MENTAL DISEASE; MORBIDITY; MORTALITY; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; PARESTHESIA; PATHOGENESIS; PRIMARY INFECTION; PROPHYLAXIS; REVIEW; SEPSIS; SHOCK; THROMBOCYTOPENIA; TREMOR; VIRUS REACTIVATION;

CYTOMEGALOVIRUS;

EID: 80051727046     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.1487     Document Type: Review

References (40)

1. Crough T and Khanna R (2009) Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev 22: 76-98.
2. Emery VC (2001) Investigation of CMV disease in immunocompromised patients. J Clin Pathol 54: 84-88.
3. Mocarski ES Jr (2004) Immune escape and exploitation strategies of cytomegaloviruses: impact on and imitation of the major histocompatibility system. Cell Microbiol 6: 707-717.
4. Cook CH, Trgovcich J, Zimmerman PD, Zhang Y, Sedmak DD (2006) Lipopolysaccharide, tumor necrosis factor alpha, or interleukin - 1β triggers reactivation of latent cytomegalovirus in immunocompetent mice. J of Virol 80: 9151-9158.
5. Hummel M and Abecassis MM (2002) A model for reactivation of CMV from latency. J Clin Virol 25: s123-136.
6. Rennekampff HO and Hemprecht K (2006) Cytomegalovirus infection in burns: a review. J of Med Microbiol 55: 483-487.
7. MC Guedes MI, Risdahl JM, Wiseman B, Molitor TW (2004) Reactivation of porcine cytomegalovirus through allogeneic stimulation. J Clin Microbiol 42: 1756-1758.
8. Muller LV, Klemn A, Weiss M, Schneider M, Suger-Wiedeck H, Durmus N, Hampl W, Mertens T (2006) Active cytomegalovirus infection in patients with septic shock. Emerg Infect Dis 12: 1517-1522.
9. Grundy JE (1990) Virologic and pathogenetic aspects of cytomegalovirus infection. Rev Infect Dis 12: S711 -S719.
10. Squizzato A, Gerdes VEA, Buller HR (2005) Effects of human cytomegalovirus infection on the coagulation system. Thromb Haemost 93: 403-410.
11. Bruggeman CA, Li F, Stals FS (1995) Pathogenicity: animal models. Scand J Infect Dis Suppl 99: 43-50.
12. Wiener-Well Y, Yinnon AM, Singer P, Hersch M (2006) Reactivation of cytomegalovirus in critically sick patients. IMAJ 8: 583-584.
13. Heininger A, Gerhard J, Corinna E, Thomas NM Klaus U, Klaus H (2001) Human cytomegalovirus infections in nonimmunosuppressed critically ill patients. Crit care medicine 29: 541-547
14. Limaye AP, Kirby KA, Rubenfeld GD, Leisenring WM, Bulger EM, Neff MJ, Gibran NS, Huang ML, Santo Hayes TK, Corey L, Boeckh M (2008) Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA 300: 413-422.
15. Jaber S, Chanques G, Borry J, Souche B, Verdier R, Perrigault PF, Eledjam JJ (2005) Cytomegalvirus infection in critically ill patients. Chest 127: 233-241.
16. Osawa R and Singh N (2009) Cytomegalovirus infection in critically ill patients: a systematic review. Crit care 13: R68.
17. Rafailidis PI, Mourtzoukou EG, Varbobitis IC, Falagas ME (2008) Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virology Journal 5: 47.
18. Ljungman P, Griffiths P, Paya C (2002) Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 34: 1094-1097
19. Erice A, Holm MA, Gill PC, Henry S, Dirksen C, Dunn D, Hillam RP, Balfour HH (1992) Cytomegalovirus (CMV) antigenemia assay is more sensitive than shell vial cultures for rapid detection of CMV in polymorphonuclear blood leukocytes. J of Clin Microbiol 30: 2822-2825.
20. Cariani E, Pollara CP, Valloncini B, Perendin F, Bonganti C, Manca N (2007) Relationship between pp65 antigenemia levels and real time quantitative DNA PCR for human cytomegalovirus (HCMV) management in immunocompromised patients. BMC Infects Dis 7: 138.
21. Zhang S, Zhou YH, LI L, Hu Y (2010) Monitoring human cytomegalovirus infection with nested PCR: comparison of positive rates in plasma and leucocytes and with quantitative PCR. Virol J 7: 73.
22. Muller L, Hampl W, Hinz J, Meisel H, Reio A, Engelman E (2003) High Variability between Results of Different In-House Tests for Cytomegalovirus (CMV) Monitoring and a Standardized Quantitative Plasma CMV PCR Assay. J of Clin Microbiol 40: 2285-2287.
23. Hinnant KL, Rotterdam HZ, Bell ET, Tapper ML (1986) Cytomegalovirus infection of the alimentary tract: a clinicopathological correlation. Am J Gastroenterol 81: 944-950.
24. Boeckh M and Boivin G (1998) Quantitation of Cytomegalovirus: Methodologic aspects and clinical application. Clin Microbiol Rev 11: 533-554.
25. Gimeno C, Solano C, Latorre JC, Hernández-Boluda JC, Clari MA, Remigia MJ, Furió S, Calabuig M, Tormo N, Navarro D (2008) Quantification of DNA in plasma by an automated real-time PCR assay (cytomegalovirus PCR kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic stem cell transplant recipients. J Clin Microbiol 46: 3311-3318.
26. Hendrix RMG, Wagenaar M, Slobbe RL, Bruggeman CA (1997) Widespread presence of cytomegalovirus DNA in tissues of healthy trauma victims. J Clin Pathol 50: 59-63.
27. Domart Y, Trouillet JL, Fagon JY, Chastre J, Brun-Vezinet F, Gibert C (1990) Incidence and morbidity of cytomegaloviral infection in patients with mediastinitis following cardiac surgery. Chest 97: 18-22.
28. Papazian L, Fraisse A, Garbe L, Zandotti C, Thomas P, Saux P, Pierrin G, Gouin F (1996) Cytomegalovirus: an unexpected cause of ventilator-associated pneumonia. Anesthesiology 84: 280-287.
29. Halme L, Lempinen M, Arola J, Sarkio S, Höckerstedt K, Lautenschlager I (2008) High frequency of gastroduodenal cytomegalovirus infection in liver transplant patients. APMIS 116: 99-106.
30. Van Gool S, Van Casteren L, Buchel O, Frans E, Dedeurwaerdere F, Van Olmen A, D'Haens G, Moons V, Christiaens P (2008) Cytomegalovirus colitis in an apparently immunocompetent host after biliopancreatic diversion for obesity. Acta Gastroenterol Belg 71: 423-426.
31. Galiatsatos P, Shrier I, Lamoureux E, Szilagyi A (2005) Meta-analysis of outcome of cytomegalovirus colitis in immunocompetent hosts. Dig Dis Sci 50: 609-616.
32. Squizzato A, Ageno W, Cattaneo A, Brumana N (2007) A Case Report and literature review of portal vein thrombosis associated with Cytomegalovirus infection in immunocompetent patients. Clin Infect Dis 44: e13-16.
33. Rafailidis PI, Kapaskelis A, Falagas ME (2007) Cytomegalovirus meningitis in an immunocompetent patient. Med Sci Monit 13: CS107-CS109.
34. Campbell PT, Li JS, Wall TC, O'Connor CM, Van Trigt P, Kenney RT, Melhus O, Corey GR (1995) Cytomegalovirus pericarditis: a case series and review of the literature. Am J Med Sci 309: 229-234.
35. Zabiaurre L, Zapata E, Biyanda L, Castillo M, Oyarzabal I, Gutierrez-Stampa MA, Cosme A (2007) Cytomegalovirus hepatitis and myopericarditis. World J Gastroenterol 13: 647-648.
36. Fernández-Ruiz M, Muñoz-Codoceo C, López-Medrano F, Faré-García R, Carbonell-Porras A, Garfia-Castillo C, Muñoz-Gómez R, Aguado-García JM (2008) Cytomegalovirus Myopericarditis and Hepatitis in an Immunocompetent Adult: S uccessful Treatment with Oral Valganciclovir. Inter Med 47: 1963-1966.
37. Griffiths PD (2002) The treatment of cytomegalovirus infection. J of antimicrobial chemotherapy 49: 243-53.
38. Razonable RR (2008) Cytomegalovirus infection after liver transplantation: current concepts and challenges. World J Gastroenterol 14: 4849-4860.
39. Meyer E, Boland GJ, Verdonck LF (2003) Prevention of cytomegalovirus disease in recipients of allogeneic stem cell transplants. Clin Microbiol Rev 16: 647-657.
40. Forster MR, Trgovcich J, Zimmerman P, Chang A, Miller C, Klenerman P, Cook CH (2010) Antiviral prevention of sepsis induced cytomegalovirus reactivation in immunocompetent mice. Antiviral Res 85: 496-503.